The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Understanding modern-day vaccines: what you need to know
Open accessAbstract
Vaccines are considered to be one of the greatest public health achievements of the last century. Depending on the biology of the infection, the disease to be prevented, and the targeted population, a vaccine may require the induction of different adaptive immune mechanisms to be effective. Understanding the basic concepts of different vaccines is therefore crucial to understand their mode of action, benefits, risks, and their potential real-life impact on protection. This review aims to provide healthcare professionals with background information about the main vaccine designs and concepts of protection in a simplified way to improve their knowledge and understanding, and increase their confidence in the science of vaccination ( Supplementary Material ). KEY MESSAGE Different vaccine designs, each with different advantages and limitations, can be applied for protection against a particular disease. Vaccines may contain live-attenuated pathogens, inactivated pathogens, or only parts of pathogens and may also contain adjuvants to stimulate the immune responses. This review explains the mode of action, benefits, risks and real-life impact of vaccines by highlighting key vaccine concepts. An improved knowledge and understanding of the main vaccine designs and concepts of protection will help support the appropriate use and expectations of vaccines, increase confidence in the science of vaccination, and help reduce vaccine hesitancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.-J., Levin, M. J., McElhaney, J. E., Poder, A., Puig-Barberà, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501184 · Cited by 1,454
Immunological mechanisms of vaccination
Pulendran, B., & Ahmed, R. (2011) · Nature Immunology · doi:10.1038/ni.2039 · Cited by 1,089
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603800 · Cited by 1,070
Herd Immunity: History, Theory, Practice
Fine, P. E. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036121 · Cited by 905
Vaccine hesitancy and healthcare providers
Paterson, P., Meurice, F., Stanberry, L. R., Glismann, S., Rosenthal, S. L., & Larson, H. J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.042 · Cited by 897
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
Vaccine Adjuvants: from 1920 to 2015 and Beyond
Pasquale, A., Preiss, S., Silva, F., & Garçon, N. (2015) · Vaccines · doi:10.3390/vaccines3020320 · Cited by 648
Monath, T. P. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.4.553 · Cited by 467
Fundamentals of vaccine immunology
Clem, A. (2011) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.77299 · Cited by 435
Delany, I., Rappuoli, R., & De Gregorio, E. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201403876 · Cited by 420
Vaccines, new opportunities for a new society
Rappuoli, R., Pizza, M., Del Giudice, G., & De Gregorio, E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402981111 · Cited by 335
History of Sabin attenuated poliovirus oral live vaccine strains
Sabin, A. B., & Boulger, L. R. (1973) · Journal of Biological Standardization · doi:10.1016/0092-1157(73)90048-6 · Cited by 319
Current and next generation influenza vaccines: Formulation and production strategies
Soema, P. C., Kompier, R., Amorij, J.-P., & Kersten, G. F. A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.023 · Cited by 314
Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant's immune system?
Offit, P. A., Quarles, J., Gerber, M. A., Hackett, C. J., Marcuse, E. K., Kollman, T. R., Gellin, B. G., & Landry, S. (2002) · Pediatrics · doi:10.1542/peds.109.1.124 · Cited by 312
Japanese encephalitis: The virus and vaccines
Yun, S.-I., & Lee, Y.-M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26902 · Cited by 288
Kornum, B. R., Knudsen, S., Ollila, H. M., Pizza, F., Jennum, P. J., Dauvilliers, Y., & Overeem, S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.100 · Cited by 285
Vaccine impact: Benefits for human health
Doherty, M., Buchy, P., Standaert, B., Giaquinto, C., & Prado- Cohrs, D. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.025 · Cited by 272
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
Pichichero, M. E. (2013) · Human vaccines & immunotherapeutics · doi:10.4161/hv.26109 · Cited by 261
Vaccines Through Centuries: Major Cornerstones of Global Health
Hajj Hussein, I., Chams, N., Chams, S., El Sayegh, S., Badran, R., Raad, M., Gerges-Geagea, A., Leone, A., & Jurjus, A. (2015) · Frontiers in Public Health · doi:10.3389/fpubh.2015.00269 · Cited by 244
From discovery to licensure, the Adjuvant System story
Garçon, N., & Di Pasquale, A. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1225635 · Cited by 217
Developing vaccines in the era of genomics: a decade of reverse vaccinology
Seib, K. L., Zhao, X., & Rappuoli, R. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03939.x · Cited by 215
DNA vaccines: roles against diseases
Khan, K. H. (2013) · GERMS · doi:10.11599/germs.2013.1034 · Cited by 212
Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
Sridhar, S., Brokstad, K., & Cox, R. (2015) · Vaccines · doi:10.3390/vaccines3020373 · Cited by 209
Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis
Sarkanen, T. O., Alakuijala, A. P. E., Dauvilliers, Y. A., & Partinen, M. M. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.06.006 · Cited by 206
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
Deering, R. P., Kommareddy, S., Ulmer, J. B., Brito, L. A., & Geall, A. J. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.901308 · Cited by 176
Vaccinations for Pregnant Women
Swamy, G. K., & Heine, R. P. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000581 · Cited by 174
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
Guy, B., Briand, O., Lang, J., Saville, M., & Jackson, N. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.108 · Cited by 172
Mucosal vaccine delivery: Current state and a pediatric perspective
Shakya, A. K., Chowdhury, M. Y. E., Tao, W., & Gill, H. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.014 · Cited by 171
Influenza virosomes as a vaccine adjuvant and carrier system
Moser, C., Amacker, M., & Zurbriggen, R. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.15 · Cited by 169
Vaccine development: From concept to early clinical testing
Cunningham, A. L., Garçon, N., Léo, O., Friedland, L. R., Strugnell, R. A., Laupèze, B., Doherty, M. T., & Stern, P. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.016 · Cited by 164
Self-citationKim, T. H., Johnstone, J., & Loeb, M. B. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.582247 · Cited by 154
Influenza virosomes as vaccine adjuvant and carrier system
Moser, C., Müller, M., Kaeser, M. D., Weydemann, U., & Amacker, M. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.811195 · Cited by 150
Siegrist, C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00004-5 · Cited by 137
Hepatitis B vaccines: Protective efficacy and therapeutic potential
Michel, M.-L., & Tiollais, P. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.01.006 · Cited by 136
Recombinant subunit vaccines: potentials and constraints.
Clark, T. G., & Cassidy-Hanley, D. (2005) · PubMed · Cited by 119
Vernikos, G. S., & Medini, D. (2014) · Pathogens and Global Health · doi:10.1179/2047773214y.0000000162 · Cited by 104
Bröker, M., Berti, F., Schneider, J., & Vojtek, I. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.078 · Cited by 103
POOLMAN, J. T., Frasch, C. E., Nurkka, A., Käyhty, H. M., Biemans, R., & Schuerman, L. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00402-10 · Cited by 101
Human papillomavirus vaccination: the population impact
Lee, L., & Garland, S. M. (2017) · F1000Research · doi:10.12688/f1000research.10691.1 · Cited by 100
RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap
Kaslow, D. C., & Biernaux, S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.061 · Cited by 92
Safety of oral poliomyelitis vaccine: results of a WHO enquiry.
Esteves, K. (1988) · Europe PMC (PubMed Central) · Cited by 61
Monath, T. P. C., Gershman, M. D., Staples, J. E., & Barrett, A. D. T. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00043-4 · Cited by 61
Alum: an old dog with new tricks
Wen, Y., & Shi, Y. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.40 · Cited by 60
Vector-based genetically modified vaccines: Exploiting Jenner’s legacy
Ramezanpour, B., Haan, I., Osterhaus, A. D. M. E., & Claassen, E. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.059 · Cited by 58
Strugnell, R. A., Zepp, F., Cunningham, A. L., & Tantawichien, T. (2011) · Perspectives in Vaccinology · doi:10.1016/j.pervac.2011.05.003 · Cited by 58
Carbohydrate-Based Vaccines: An Overview
Hütter, J., & Lepenies, B. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2874-3_1 · Cited by 55 · cited 1×
“due to the immaturity of their immune system [51].”
BackgroundThe RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination
Vandoolaeghe, P., & Schuerman, L. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1236689 · Cited by 52
Complete DNA Sequences of Two Oka Strain Varicella-Zoster Virus Genomes
Tillieux, S. L., Halsey, W. S., Thomas, E. S., Voycik, J. J., Sathe, G. M., & Vassilev, V. B. (2008) · Journal of Virology · doi:10.1128/jvi.00777-08 · Cited by 48
The present and future of tuberculosis vaccinations
Principi, N., & Esposito, S. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.10.004 · Cited by 44
The re-emergency and persistence of vaccine preventable diseases
Borba, R., Vidal, V. M., & Moreira, L. O. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140663 · Cited by 37
Shirley, M., & Dhillon, S. (2015) · BioDrugs · doi:10.1007/s40259-015-0139-0 · Cited by 37
Edwards, K. M., & Decker, M. D. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00030-6 · Cited by 36
Tillieux, S. L., Halsey, W. S., Sathe, G. M., & Vassilev, V. B. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.112 · Cited by 34
Stanberry, L. R., & Strugnell, R. A. (2011) · Perspectives in Vaccinology · doi:10.1016/j.pervac.2011.05.006 · Cited by 20
Technologies for making new vaccines
Ellis, R. W., Rappuoli, R., & Ahmed, S. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00013-6 · Cited by 14
Cited by
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
Hassett, K. J., Higgins, J., Woods, A., Levy, B., Xia, Y., Hsiao, C. J., Acosta, E., Almarsson, Ö., Moore, M. J., & Brito, L. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.021 · Cited by 367
Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization
Wang, N., Chen, M., & Wang, T. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.025 · Cited by 308
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Pollet, J., Chen, W.-H., & Strych, U. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.001 · Cited by 277
Naik, G. A. R. R., Roy, A. A., Mutalik, S., & Dhas, N. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134977 · Cited by 47
Metadata
- Authors
- Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., & Shapiro, M.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2017-11-27
- Volume
- 50
- Issue
- 2
- Pages
- 110-120
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W2771056997
- Cited by
- 354
- References
- 55
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.